Literature DB >> 21896999

Platelet-stored angiogenesis factors: clinical monitoring is prone to artifacts.

Patrick Starlinger1, Lejla Alidzanovic, Dominic Schauer, Philipp Brugger, Silvia Sommerfeldt, Irene Kuehrer, Sebastian F Schoppmann, Michael Gnant, Christine Brostjan.   

Abstract

BACKGROUND: The analysis of angiogenesis factors in the blood of tumor patients has given diverse results on their prognostic or predictive value. Since mediators of angiogenesis are stored in platelets, their measurement in plasma is sensitive to inadvertent platelet activation during blood processing.
METHODS: Variants of blood withdrawal and plasma preparation were evaluated by ELISA for the detection of TSP-1, PF-4, VEGF and PD-ECGF. A total of 22 pancreatic cancer patients and 29 healthy volunteers were evaluated.
RESULTS: Plasma preparation with the anticoagulant mix of citrate, theophylline, adenosine, dipyridamole (CTAD) and immediate blood processing at 4°C was required for reproducible measurements of TSP-1, PF-4 and VEGF. Blood collection by venflon or inadvertent hemolysis during blood withdrawal caused significantly elevated TSP-1 and PF-4 values. When optimized plasma preparation was applied, a significant increase of TSP-1 and VEGF in cancer patients was detected (P=0.006; P< 0.001).
CONCLUSION: The reliable plasma analysis of circulating platelet-stored angiogenesis factors requires preparation with CTAD at 4°C and blood collection by butterfly needle. Suboptimal procedures of plasma preparation are commonly applied in clinical monitoring of angiogenesis parameters which may account for the differences in reported plasma values and may have masked their predictive or prognostic marker potential.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21896999      PMCID: PMC3826483          DOI: 10.3233/DMA-2011-0798

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  19 in total

1.  A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515.

Authors:  Alison T Stopeck; Joseph M Unger; Lisa M Rimsza; Michael LeBlanc; Brent Farnsworth; Maria Iannone; Martha J Glenn; Richard I Fisher; Thomas P Miller
Journal:  Blood       Date:  2012-06-25       Impact factor: 22.113

2.  A systematic review and meta-analysis of preanalytical factors and methodological differences influencing the measurement of circulating vascular endothelial growth factor.

Authors:  Ulrika Sjöbom; Anders K Nilsson; Hanna Gyllensten; Ann Hellström; Chatarina Löfqvist
Journal:  PLoS One       Date:  2022-07-06       Impact factor: 3.752

3.  Intermediate monocytes but not TIE2-expressing monocytes are a sensitive diagnostic indicator for colorectal cancer.

Authors:  Dominic Schauer; Patrick Starlinger; Christian Reiter; Nikolaus Jahn; Philipp Zajc; Elisabeth Buchberger; Thomas Bachleitner-Hofmann; Michael Bergmann; Anton Stift; Thomas Gruenberger; Christine Brostjan
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

4.  Deficiency in thrombopoietin induction after liver surgery is associated with postoperative liver dysfunction.

Authors:  Stefanie Haegele; Florian Offensperger; David Pereyra; Elisabeth Lahner; Alice Assinger; Edith Fleischmann; Birgit Gruenberger; Thomas Gruenberger; Christine Brostjan; Patrick Starlinger
Journal:  PLoS One       Date:  2015-01-22       Impact factor: 3.240

5.  Monocytes with angiogenic potential are selectively induced by liver resection and accumulate near the site of liver regeneration.

Authors:  Dominic Schauer; Patrick Starlinger; Philipp Zajc; Lejla Alidzanovic; Thomas Maier; Elisabeth Buchberger; Lorand Pop; Birgit Gruenberger; Thomas Gruenberger; Christine Brostjan
Journal:  BMC Immunol       Date:  2014-10-30       Impact factor: 3.615

6.  Levels of a subpopulation of platelets, but not circulating endothelial cells, predict early treatment failure in prostate cancer patients after prostatectomy.

Authors:  C K E Wong; B Namdarian; J Chua; X Chin; R Speirs; T Nguyen; M Fankhauser; J Pedersen; A J Costello; N M Corcoran; C M Hovens
Journal:  Br J Cancer       Date:  2012-10-09       Impact factor: 7.640

7.  Platelet activation determines angiopoietin-1 and VEGF levels in malaria: implications for their use as biomarkers.

Authors:  Judith Brouwers; Rintis Noviyanti; Rob Fijnheer; Philip G de Groot; Leily Trianty; Siti Mudaliana; Mark Roest; Din Syafruddin; Andre van der Ven; Quirijn de Mast
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

8.  Pre-Analytical Parameters Affecting Vascular Endothelial Growth Factor Measurement in Plasma: Identifying Confounders.

Authors:  Johanna M Walz; Daniel Boehringer; Heidrun L Deissler; Lothar Faerber; Jens C Goepfert; Peter Heiduschka; Susannah M Kleeberger; Alexa Klettner; Tim U Krohne; Nicole Schneiderhan-Marra; Focke Ziemssen; Andreas Stahl
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

9.  Inhibition of thrombospondin-1 reduces glutathione activity and worsens acute liver injury during acetaminophen hepatotoxicity in mice.

Authors:  Gabriel Frampton; Priyanka Reddy; Brandi Jefferson; Malaika Ali; Durreshahwar Khan; Matthew McMillin
Journal:  Toxicol Appl Pharmacol       Date:  2020-11-08       Impact factor: 4.219

10.  Consequences of Perioperative Serotonin Reuptake Inhibitor Treatment During Hepatic Surgery.

Authors:  Rory L Smoot; Thomas Gruenberger; Patrick Starlinger; David Pereyra; Hubert Hackl; Gregor Ortmayr; Eva Braunwarth; Jonas Santol; Sina Najarnia; Michael R Driedger; Lindsey Gregory; Roberto Alva-Ruiz; Amy Glasgow; Alice Assinger; David M Nagorney; Elizabeth B Habermann; Stefan Staetttner; Sean P Cleary
Journal:  Hepatology       Date:  2021-03-16       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.